News

  • Daktari Awarded NIH SBIR for New Sickle Cell Diagnostic Test – 22 September 2014
    Daktari Diagnostics, in collaboration with Harvard University, the Medical University of South Carolina, and the University of Zambia in Lusaka, is thrilled to announce that it has been awarded a Small Business Innovation Research (SBIR) grant by the National Institute of Health (NIH) for a point-of-care sickle cell diagnostic test. [Press Release]
  • Daktari Accepted into WHO Prequalification of Diagnostics Programme – 18 July 2014
    Daktari Diagnostics is pleased to announce the acceptance of the Daktari CD4 Instrument into the Prequalification of Diagnostics Programme within the World Health Organization (WHO). [Press Release]
  • Daktari Continues Support of ASLM – 9 July 2014
    Daktari Diagnostics is proud to announce its continued support of the African Society for Laboratory Medicine as the Strategic Partner Sponsor of ASLM’s second international conference in Cape Town, South Africa. [Press Release]
  • Daktari Awarded NIH Phase I SBIR for its HCV Diagnostic – 2 June 2014
    The National Institute of Health has awarded a Phase I Small Business Innovation Research (SBIR) grant to Daktari Diagnostics for a point-of-care hepatitis C diagnostic system. [Press Release]
  • Daktari Awarded $2.7 M Grant from UNITAID to Commercialize CD4 System – 14 March 2014
    Daktari Diagnostics, which is commercializing a diagnostic platform to meet the health care needs in Africa, Asia, and resource-limited settings worldwide, has been awarded a UNITAID grant for $2.68 million to commercialize its point-of-care CD4 system in seven African countries. [Press Release]
  • Daktari Receives Tax Grant from Massachusetts Life Sciences Center – 27 February 2014
    Daktari Diagnostics is pleased to announce it has received a $347,000 tax incentive award from the Massachusetts Life Sciences Center (MLSC) in exchange for a commitment to add 17 new jobs over the next 12 months. Daktari was one of 33 Commonwealth companies to receive an award. [Press Release]
  • Daktari Attains ISO 13485 Certification – 14 January 2014
    Daktari Diagnostics, which is commercializing a diagnostic platform to meet the health care needs in Africa, Asia, and resource-limited settings worldwide, has received ISO 13485 certification, the Company announced today. [Press Release]
  • New Daktari Technology Highlighted in Science Translational Medicine – 4 December 2013
    A new sensor technology developed by researchers at the University of Illinois at Urbana-Champaign and collaborators at Daktari Diagnostics can monitor HIV and measure white blood counts using just a drop of blood. [Read More...]
  • Mike Fritschy Joins Daktari as Executive Vice President, Operations – 3 September 2013
    Daktari is pleased to announce that Mike Fritschy has joined Daktari as its Executive Vice President of Operations. [Press Release]
  • Daktari Partners with African Society of Laboratory Medicine at ASLM 2012 – 4 December 2012
    Daktari Diagnostics is proud to support the African Society of Laboratory Medicine (ASLM) at its first major scientific conference this week in Cape Town, South Africa. [Read More...]
  • Boston’s Most Visible Companies – 31 May 2012
    Read the article here.
  • Fred Farber Joins Daktari as Chief Technology Officer – 4 April 2012
    Fred Farber, who co-founded the women’s health company Cytyc and led the development of the ThinPrep™ system for detecting cervical cancer, has joined Daktari as its Chief Technology Officer. [Press Release]
  • Daktari Diagnostics Announces $10 Million in Financing – 21 December 2011
    Daktari Diagnostics announces that it has secured $10 million in a staged financing round from a syndicate of private and venture investors. [Press Release]
  • Partners Innovation Fund and Daktari Diagnostics, Inc. Close Series A Financing and Sign License Agreement with Massachusetts General Hospital – 4 September 2009
    Partners Innovation Fund and Daktari Diagnostics, Inc. (www.daktaridx.com), a company developing point-of-care diagnostics for infectious diseases, announced today the closing of a $2.8MM Series A financing. [Press Release]

Twitter